TE_14
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MLT1G3 |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | HES4 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.23 |
| Counts of samples | TCGA_tumor:111; TCGA_normal:24; GTEx:78 |
| TSS | chr1(-):1003580 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_14.1 | HES4 | Chimeric | Non-coding | Non-coding | chr1(-):999412,999432,999526,999613,999692,999787,999866,1001290,1003537,1003581 |
| teRNA_14.2 | HES4 | Chimeric | Non-coding | Non-coding | chr1(-):999412,999432,999526,999613,999866,1001290,1003537,1003581 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
